Risankizumab : Injection 75 mg in 0.83 mL pre-filled syringe; Skyrizi® Page last updated: 6 March 2020 Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)